A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.
SINGAPORE: The updated JN.1 Novavax/Nuvaxovid COVID-19 vaccine will be offered under the national vaccination programme at ...
From today, Kiwis over 30 will be able to access the latest Covid-19 vaccine. How does it work and what makes it better than the last one? Science reporter Jamie Morton explains. By training our ...
The CDC ACIP recommends 2 doses of the 2024-2025 COVID-19 vaccine for those age 65+ years and 2 or more doses for immunocompromised individuals.
Rising diagnoses of certain cancers in people under 50 predate the rollout of COVID-19 vaccines by decades, undermining ...
The rapid creation of COVID-19 vaccinations saved millions of lives around the world, but it was followed by hundreds of ...
We thank our colleagues for their interest in our Article.1 In response to Ari R Joffe, we provided estimates of the number of severe outcomes associated with a fully vaccinated counterfactual. These ...
So far, 59 people in Pune have been diagnosed with Guillain-Barré Syndrome (GBS), a rare neurological disorder. Authorities have yet to identify the cause of the outbreak. However, rumours have been ...
Patients who received the original monovalent mRNA COVID-19 vaccine were less likely than unvaccinated patients to be hospitalized for COVID-19-associated VTE.
Researchers from the Massachusetts Institute of Technology (MIT) and the California Institute of Technology (Caltech) have made significant strides in vaccine development that could protect against ...